Is an SGLT2 inhibitor right for your patient with type 2 diabetes?

被引：0
作者：
Lisenby, Katelin M. [1 ]
Meyer, Allison [1 ]
Slater, Nicole A. [1 ]
机构：
[1] Auburn Univ, Harrison Sch Pharm, Dept Pharm Practice, Tuscaloosa, AL USA
来源：
JOURNAL OF FAMILY PRACTICE | 2016年 / 65卷 / 09期
关键词：
INADEQUATE GLYCEMIC CONTROL; METFORMIN PLUS SULFONYLUREA; LONG-TERM EFFICACY; ADD-ON THERAPY; DOUBLE-BLIND; BACKGROUND METFORMIN; SAFETY; EMPAGLIFLOZIN; PLACEBO; CANAGLIFLOZIN;
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：587 / 593
页数：7
相关论文
共 50 条
[31]   Prevalence of Genitourinary Infections with Sodium Glucose Co-transporter-2 (sglt2) inhibitors in patients with type 2 diabetes [J].
Hussain, Mazhar ;
Hussain, Abid ;
Rehman, Habib Ur ;
Iqbal, Javed .
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (10) :2804-2807
[32]   Renoprotection with SGLT2 inhibitors in type 2 diabetes over a spectrum of cardiovascular and renal risk [J].
Giorgino, Francesco ;
Vora, Jiten ;
Fenici, Peter ;
Solini, Anna .
CARDIOVASCULAR DIABETOLOGY, 2020, 19 (01)
[33]   Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus [J].
Azizogli, Abdul-Rahman ;
Vitti, Michael R. ;
Mishra, Richa ;
Osorno, Laura ;
Heffernan, Corey ;
Kumar, Vivek A. .
ADVANCED THERAPEUTICS, 2023, 6 (12)
[34]   SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes? [J].
Saisho, Yoshifumi .
DISEASES, 2020, 8 (02)
[35]   SGLT2: a potential target for the pharmacogenetics of Type 2 diabetes? [J].
Toenjes, Anke ;
Kovacs, Peter .
PHARMACOGENOMICS, 2013, 14 (07) :825-833
[36]   The role of SGLT2 inhibitors in managing type 2 diabetes [J].
Tat, Velen ;
Forest, Christopher P. .
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2018, 31 (06) :35-40
[37]   Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits [J].
Lupsa, Beatrice C. ;
Inzucchi, Silvio E. .
DIABETOLOGIA, 2018, 61 (10) :2118-2125
[38]   Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus [J].
Abdul-Ghani, Muhammad A. ;
Norton, Luke ;
DeFronzo, Ralph A. .
CURRENT DIABETES REPORTS, 2012, 12 (03) :230-238
[39]   Evaluating SGLT2 inhibitors for type 2 diabetes: pharmacokinetic and toxicological considerations [J].
Scheen, Andre J. .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) :647-663
[40]   Clinical implication of SGLT2 inhibitors in type 2 diabetes [J].
Kim, Go Woon ;
Chung, Sung Hyun .
ARCHIVES OF PHARMACAL RESEARCH, 2014, 37 (08) :957-966
12345